Dysglycemia and the Density of the Coronary Vasa Vasorum
Hertzel C. Gerstein(McMaster University), Geoff H. Werstuck(McMaster University), Vidhya Nair(University Health Network), Heidi Stoute(Thrombosis and Atherosclerosis Research Institute), Ruchi Chaube(University Hospitals of Cleveland)
Cited by 23
Related Papers
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Myocardial Injury after Noncardiac Surgery
|Anesthesiology|2014|979
Cardiac tumours: diagnosis and management
|The Lancet Oncology|2005|848
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
|Journal of Clinical Investigation|2001|702